Mini Podcast Series Episode 3: Beyond Buzzwords - Have Decentralized Clinical Trials Become the New Norm
Episode 3 of "Through the Biotech Lens: Molecule to Market" features Jerome Armellini and Dr. Craig Underhill as they delve into how the COVID-19 pandemic has accelerated the adoption of decentralized clinical trials. Learn about the benefits of these decentralized trials and how IQVIA's technology platforms brings the decentralized solution to life and benefits patients directly.